LeadStory

Africanews

U.S. limits new COVID-19 vaccines to high-risk groups

Africanews · Just In
Africanews
Africanews
Just In

The new guidance marks a major shift from previous policy, which recommended annual COVID-19 shots for all Americans six months and older.

Breakdown
  • FDA approves updated COVID-19 vaccines from Pfizer, Moderna, and Novavax.
  • Vaccines now recommended only for seniors or those with high-risk conditions. 11s
  • Pfizer's vaccine no longer available for children under 5; Moderna's limited to high-risk young children. 19s
  • Distribution of new vaccines may be delayed and depends on insurers, pharmacies, and authorities. 39s
  • Healthy adults and children may face barriers and out-of-pocket costs over $150. 48s
HealthCOVID-19